Ipilimumab with fotemustine in metastatic melanoma

Lancet Oncol. 2012 Sep;13(9):851-2. doi: 10.1016/S1470-2045(12)70341-8. Epub 2012 Aug 13.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / secondary*
  • Female
  • Humans
  • Ipilimumab
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary*
  • Nitrosourea Compounds / administration & dosage*
  • Organophosphorus Compounds / administration & dosage*
  • Skin Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Ipilimumab
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine